TARS
Tarsus Pharmaceuticals Inc
74.50$
+2.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +5.9% | -227.5% | – | – | |
| – | +42.2% | -22.2% | -11.5% | +18.8% | +52.1% | +6.5% | -1.5% | -11.7% | +10.7% | -1.4% | +128.8% | – | |
| – | +4.4% | +0.7% | +35.5% | -0.9% | -0.2% | -6.4% | +18.8% | +48.7% | +16.9% | -16.4% | +11.0% | – | |
| – | -299.8% | – | – | -116.2% | – | – | – | – | -29.8% | -317.1% | – | – | |
| – | -8.6% | -95.7% | +497.1% | -72.9% | +1,698.6% | -88.4% | +69.7% | +90.8% | +232.9% | -8.5% | -30.1% | – | |
| – | -62.3% | -672.7% | -60.4% | – | -2,004.5% | -41.3% | +48.0% | -90.8% | – | -218.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -81.2% | +450.5% | -61.1% | -98.5% | +358.1% | +4,565.6% | -98.6% | +31.3% | -9.8% | -47.9% | +193.7% | – | |
| – | -101.4% | – | – | – | – | – | -197.7% | – | +341.1% | -215.6% | – | – | |
| – | – | – | – | – | – | – | – | – | -20.6% | -334.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.